Presentation is loading. Please wait.

Presentation is loading. Please wait.

Tumors of the esophagogastric junction

Published byVeronica Baker Modified over 5 years ago

Similar presentations

Presentation on theme: "Tumors of the esophagogastric junction"— Presentation transcript:

1 Tumors of the esophagogastric junction
W.H. Steup, MD, PhD (by invitation), P. De Leyn, MD, PhD (by invitation), G. Deneffe, MD (by invitation), D. Van Raemdonck, MD (by invitation), W. Coosemans, MD (by invitation), T. Lerut, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 111, Issue 1, Pages (January 1996) DOI: /S (96)70404-X Copyright © 1996 Mosby, Inc. Terms and Conditions

2 Fig. 1 Overall survival in years after resection for tumors of the esophagogastric junction. The Journal of Thoracic and Cardiovascular Surgery  , 85-95DOI: ( /S (96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

3 Fig. 2 Survival curves according to pTNM staging after resection for tumors of the esophagogastric junction. The Journal of Thoracic and Cardiovascular Surgery  , 85-95DOI: ( /S (96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

4 Fig. 3 Survival curves according to absence or presence of lymph node involvement after resection for tumors of the esophagogastric junction. The Journal of Thoracic and Cardiovascular Surgery  , 85-95DOI: ( /S (96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

5 Fig. 4 Survival curves according to lymph node involvement of abdominal and abdominal plus thoracic lymph nodes after resection for tumors of the esophagogastric junction. LN, Lymph node; +, positive (diseased); -, negative (normal). The Journal of Thoracic and Cardiovascular Surgery  , 85-95DOI: ( /S (96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

6 Fig. 5 Survival curves according to pTNM staging after resection for tumors of the esophagogastric junction that were classified as esophageal carcinomas. The Journal of Thoracic and Cardiovascular Surgery  , 85-95DOI: ( /S (96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

7 Fig. 6 Survival curves after regrouping of patients originally classified as having IIIb or M+Ly intrathoracic disease. Patients with T4 tumors are excluded. Staging is classified as gastric carcinoma. The Journal of Thoracic and Cardiovascular Surgery  , 85-95DOI: ( /S (96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

Download ppt "Tumors of the esophagogastric junction"

Similar presentations

Fig. 1: Regional abdominal lymph node dissection during 2-field LND. Fig. 2: full mobilisation of spleen and pancreatic tail to allow complete LND of.

Fig. 1: Regional abdominal lymph node dissection during 2-field LND. Fig. 2: full mobilisation of spleen and pancreatic tail to allow complete LND of.
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the.

Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the.
Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,
Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients  Ze Fen Xiao, MD, Zong Yi Yang, MD, Jun Liang, MD, Yan.

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients  Ze Fen Xiao, MD, Zong Yi Yang, MD, Jun Liang, MD, Yan.
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Survival of patients with distal esophageal and gastric cardia tumors: A population- based analysis of gastroesophageal junction carcinomas  Bryan A. Whitson,

Survival of patients with distal esophageal and gastric cardia tumors: A population- based analysis of gastroesophageal junction carcinomas  Bryan A. Whitson,
Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy  John J. Nigro, MD, Steven R. DeMeester, MD, Jeffrey A. Hagen,

Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy  John J. Nigro, MD, Steven R. DeMeester, MD, Jeffrey A. Hagen,
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Surgical treatment of thoracoabdominal aortic aneurysms by simple crossclamping: Risk factors and late results  Marc A.A.M. Schepens, MD, Jo J.A.M. Defauw,

Surgical treatment of thoracoabdominal aortic aneurysms by simple crossclamping: Risk factors and late results  Marc A.A.M. Schepens, MD, Jo J.A.M. Defauw,
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Factors predictive of prognosis after esophagectomy for squamous cell cancer  Houhuai Li, MD, PhD, Qingzhen Zhang, Lin Xu, MD, Yijiang Chen, Yongxiang.

Factors predictive of prognosis after esophagectomy for squamous cell cancer  Houhuai Li, MD, PhD, Qingzhen Zhang, Lin Xu, MD, Yijiang Chen, Yongxiang.
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy  Morihito Okada, MD, Hiroyuki Yamagishi,

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy  Morihito Okada, MD, Hiroyuki Yamagishi,
Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E
Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 
Victor van Berkel, MD, PhD 

Victor van Berkel, MD, PhD 
Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 

Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 

Similar presentations

Ads by Google